{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-081607","form_type":"8-K","ticker":"BOLT","cik":"0001641281","company_name":"Bolt Biotherapeutics, Inc.","filed_at":"2025-06-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.169047+00:00","generated_at":"2026-05-19T23:57:55.012741+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Bolt Biotherapeutics announces 1-for-20 reverse stock split effective June 6, 2025","bullets":["Reverse stock split ratio 1:20 approved by board on May 27, 2025.","Effective at 5:00pm ET on June 6, 2025; trading starts split-adjusted June 9.","Ticker remains BOLT on Nasdaq Capital Market; new CUSIP 097702203.","No fractional shares issued; cash paid in lieu of fractional shares.","Par value unchanged at $0.00001; all shares and equity awards adjusted proportionally."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-081607","json":"https://secwatch.observer/filing/0000950170-25-081607.json","markdown":"https://secwatch.observer/filing/0000950170-25-081607.md","text":"https://secwatch.observer/filing/0000950170-25-081607.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641281/000095017025081607/0000950170-25-081607-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641281/000095017025081607/bolt-20250604.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T23:57:55.012741+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}